e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Clincal aspects of asthma: monitoring and mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of lipoxin A4 and nitric oxide as inflammatory mediators in bronchial asthma
Abdel Monem Elshabrawi (Suez, Egypt), Fatema El Nokaly, Abd El Monem Elshabrawi, Hala El Mougy, Wafaa Abd El Fatah, Ashraf Behiry
Source:
International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Session:
Clincal aspects of asthma: monitoring and mechanisms
Session type:
Thematic Poster Session
Number:
1067
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Abdel Monem Elshabrawi (Suez, Egypt), Fatema El Nokaly, Abd El Monem Elshabrawi, Hala El Mougy, Wafaa Abd El Fatah, Ashraf Behiry. Evaluation of lipoxin A4 and nitric oxide as inflammatory mediators in bronchial asthma. Eur Respir J 2015; 46: Suppl. 59, 1067
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Decreased airway eosinophilic inflammation, hypersecretion and remodeling in mice lacking all nitric oxide synthase isoforms
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
Weak association between exhaled nitric oxide and bronchial responsiveness in asthmatic patients
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Nitric oxide oxidation products in bronchoalveolar lavage of patients with different severity of asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Imbalance of anti-inflammatory (lipoxin A4) and pro-inflammatory (leukotrien B4) arachidonic acid products in exhaled breath condensate of severe refractory asthma.
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study
Source: Eur Respir J 2011; 37: 523-531
Year: 2011
Non-invasive markers of airway eosinophilic inflammation in pre-school children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge
Source: Eur Respir J 2006; 27: 1152-1159
Year: 2006
Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Evaluation of exhaled nitric oxide and sputum eosinophils as markers of inflammation in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 176s
Year: 2003
The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Exhaled nitric oxide in asthma
Source: Eur Respir Monogr 2010; 49: 32-44
Year: 2010
Additive contribution of exhaled nitric oxide and sputum eosinophils to airway responsiveness
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Features of production nitric oxide at patients with a bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept